FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diltiazem Hydrochloride ER (Twice-a-Day) Capsules
Status: Currently in Shortage
»Date first posted: 10/18/2018
»Therapeutic Categories: Cardiovascular

Expand all

Mylan Pharmaceuticals Inc. (Reverified 01/21/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
60 mg (NDC 0378-6060-01) Available Other
90 mg (NDC 0378-6090-01) Available Other
120 mg (NDC 0378-6120-01) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English